These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 5982622

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Causes of bladder carcinoma].
    Fokkens W.
    Ned Tijdschr Geneeskd; 1973 Jul 21; 117(29):1088-94. PubMed ID: 4593760
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies in the etiology and prevention of bladder carcinoma.
    Schlegel JU, Pipkin GE, Nishimura R, Duke GA.
    Trans Am Assoc Genitourin Surg; 1968 Jul 21; 60():14-21. PubMed ID: 5746137
    [No Abstract] [Full Text] [Related]

  • 7. Bladder cancer.
    Price JM.
    Proc Can Cancer Conf; 1966 Jul 21; 6():224-43. PubMed ID: 5339766
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary excretion of carcinogenic tryptophane metabolites in cancer of bladder.
    Bapna BC, Singh SM, Nath A.
    Indian J Med Res; 1969 Mar 21; 57(3):586-8. PubMed ID: 5824015
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tryptophan, urinary quinolines, and bladder cancer.
    Williams DJ.
    Nutr Cancer; 1988 Mar 21; 11(2):81-2. PubMed ID: 3283708
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary bladder carcinogenesis.
    Cohen SM, Greenfield RE, Friedell GH.
    Pathobiol Annu; 1982 Mar 21; 12():267-80. PubMed ID: 6761632
    [No Abstract] [Full Text] [Related]

  • 15. Formal discussion: chemical and physical carcinogens.
    Nelson N.
    Cancer Res; 1965 Sep 21; 25(8):1314-6. PubMed ID: 5839723
    [No Abstract] [Full Text] [Related]

  • 16. Urinary bladder carcinogenesis with N-substituted aryl compounds: initiation and promotion.
    Cohen SM.
    Natl Cancer Inst Monogr; 1981 Dec 21; (58):63-7. PubMed ID: 7341985
    [Abstract] [Full Text] [Related]

  • 17. [Tryptophan metabolic disorder--1 of the criteria for forming groups at high risk for spontaneous bladder cancer].
    Prianichnikova MB.
    Urol Nefrol (Mosk); 1984 Dec 21; (4):61-5. PubMed ID: 6236595
    [No Abstract] [Full Text] [Related]

  • 18. Tryptophan metabolism in patients with bladder cancer: geographical differences.
    Brown RR, Price JM, Friedell GH, Burney SW.
    J Natl Cancer Inst; 1969 Jul 21; 43(1):295-301. PubMed ID: 5796394
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Bladder carcinogenesis and tryptophan metabolism].
    Matsushima M.
    Nihon Hinyokika Gakkai Zasshi; 1982 Dec 21; 73(12):1511-5. PubMed ID: 6763955
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.